Global prevalence of childhood cataract: a systematic review

S Sheeladevi1, J G Lawrenson1, A R Fielder1

  • 1Centre for Public Health Research, Division of Optometry and Visual Science, School of Health Sciences, City University London, London, UK.

Eye (London, England)
|August 13, 2016
PubMed

Insights

Childhood cataract, a leading cause of preventable vision loss, has a global prevalence ranging from 0.32 to 22.9 per 10,000 children. More research is needed, especially in low-income countries, to understand its full impact.

Area of Science:

  • Ophthalmology
  • Public Health
  • Epidemiology

Background:

  • Childhood cataract is a significant, yet avoidable, cause of visual disability globally.
  • It is a key focus area for VISION 2020: The Right to Sight initiative.
  • Current data on the global burden of childhood cataract is limited.

Purpose of the Study:

  • To systematically review and assess the global prevalence and incidence of childhood cataract.
  • To identify gaps in the epidemiological knowledge of this condition.

Main Methods:

  • Systematic literature search adhering to PRISMA guidelines.
  • Searched Cochrane Library, Medline, and Embase up to January 2015 for studies on childhood cataract prevalence/incidence.
  • Included 20 prevalence and 4 incidence studies, assessing study quality.

Main Results:

  • Overall childhood cataract prevalence ranged from 0.32 to 22.9/10,000 children (median 1.03).
  • Congenital cataract prevalence ranged from 0.63 to 9.74/10,000 (median 1.71); incidence was 1.8 to 3.6/10,000 annually.
  • Prevalence was similar in low-income (0.42-2.05/10,000) and high-income (0.63-13.6/10,000) economies, with no difference by laterality or gender.

Conclusions:

  • Substantial gaps exist in the worldwide epidemiological knowledge of childhood cataract.
  • Further research with standardized methods is crucial, particularly in low and lower-middle-income economies.
  • Understanding the true burden is essential for effective prevention and treatment strategies.

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
10.6K
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.5K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K